Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion type Assertion NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_head.
- NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion wasGeneratedBy ECO_0000203 NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_provenance.
- NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion wasDerivedFrom befree-20140225 NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_provenance.
- NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion SIO_000772 16260429 NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_provenance.
- NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion evidence source_evidence_literature NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_provenance.
- NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_assertion description "[Similarly, 76% of PTCs, 83% of FTCs and 25% of PDTCs expressed VEGFR-1, whereas 68% of PTCs, 56% of FTCs and 37% of PDTCs expressed VEGFR-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315222.RAXwPMsA8S7AMgp6eFDxUgb4P_8ip9oN3PMgDVZSVCMNU130_provenance.